Extraordinary General Meeting of shareholders to be held on October 28, 2024Sep 16, 202409-17-2024.pdfDownload PDF • 363KB
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million